Early HIV trial tests new Immune-Activating treatment
NCT ID NCT07182838
Summary
This is a very small, early-stage study testing whether a new biological treatment can help control HIV. The trial involves 20 HIV-positive patients without AIDS symptoms, who receive a combination treatment through skin injections. Researchers are looking to see if this approach can reduce HIV levels in the blood and activate the immune system's response to the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicine Invention Design Incorporation - IORG0007849 - NPI 1023387701
Rockville, Maryland, 20853, United States
Conditions
Explore the condition pages connected to this study.